Hemoglobin SC Disease: Phenotypic Variability and Therapeutic Options |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.7, No. 5)Publication Date: 2020-02-26
Authors : Bindu K Sathi;
Page : 441-448
Keywords : Hemoglobin SC disease (HbSC); Pain crisis; Splenic sequestration; Priapism; Newer therapeutics; Homozygous Sickle Cell Disease;
Abstract
Mutation in the Beta Globin Gene (HBB) leads to the formation of Hemoglobin S (HbS) and Hemoglobin C (HbC). Co-inheritance of HbS and HbC causes hemoglobin SC disease, a form of hemolytic anemia with a myriad of clinical manifestations. Valine replaces glutamic acid in the 6th position (Glu 6Val) to form HbS and Lysine replaces glutamic acid (Glu6Lys) in HbC. The interaction of HbC with HbS increases the propensity of red blood cells to sickle leading to microvascular occlusion and down-stream end organ complications.
Other Latest Articles
- Non-Conformities that Hinder Health Institution to be Accredited: Integrative Review |Biomedgrid
- Hospice Care for End of Life Client in the Culture of Mountain and Beach of Papuan |Biomedgrid
- China’s ‘Money Boys’ and HIV for the Greater Good: The Queer Body and Necropolitics |Biomedgrid
- Sharpshooter (40%Profenofos and 4% Cypermethrin)-Induced Oxidative Stress Response in African Catfish Clarias Gariepinus |Biomedgrid
- Adaptive Structures, Robotics and Bio medics: A Perspective |Biomedgrid
Last modified: 2023-05-26 21:34:58